John Joseph Hurley - 06 Mar 2026 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
Principal Accounting Officer
Signature
/s/ John S. Fischer, as attorney-in-fact for John Joseph Hurley
Issuer symbol
AVNS
Transactions as of
06 Mar 2026
Net transactions value
$0
Form type
4
Filing time
10 Mar 2026, 09:49:52 UTC
Previous filing
09 Sep 2025
Next filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hurley John Joseph Principal Accounting Officer 5405 WINDWARD PARKWAY, SUITE 100, ALPHARETTA /s/ John S. Fischer, as attorney-in-fact for John Joseph Hurley 10 Mar 2026 0001924834

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Options Exercise +919 +8.1% $13.79* 12,283 06 Mar 2026 Direct F1
transaction AVNS Common Stock Tax liability -321 -2.6% $13.79* 11,962 06 Mar 2026 Direct F2
transaction AVNS Common Stock Tax liability -144 -1.2% $13.79* 11,818 06 Mar 2026 Direct F3
transaction AVNS Common Stock Tax liability -211 -1.8% $13.79* 11,607 06 Mar 2026 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each PRSU is the economic eqiuvalent of one share of Common Stock.
F2 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 919 PRSUs which vested on March 6, 2026.
F3 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 413 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 6, 2023 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.
F4 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 604 TRSUs which: (i) were awarded to the Reporting Person on March 6, 2024 and (ii) vested on March 6, 2026. Each TRSU is the economic equivalent of one share of Common Stock.